DURHAM – Infinia ML, an artificial intelligence startup co-founded by Duke Professor Lawrence Carin and Triangle serial entrepreneur Robbie Allen, has been sold.
The buyer is Georgia-based Aspirion.
Financial terms were not disclosed.
“Our focus on innovation is key to Aspirion’s ability to maximize collections and accelerate revenue recovery for our healthcare system and hospital partners’ most challenging receivables. Innovation is core to our organizational structure and culture, from our highly skilled team to our best-in-class workflows powered by our proprietary Compass platform,” said Amy Amick, CEO of Aspirion. “Infinia ML brings the preeminent team of data scientists, strategists, and technologists with extensive AI capabilities and a scalable technology platform with a proven track record of success. Combining Infinia ML’s expertise with Aspirion’s deep RCM experience and market reach, we are uniquely positioned to further elevate revenue cycle performance for our client partners. Our investments to date in AI, machine learning, and robotic process automation have yielded strong value for our clients. The acquisition of Infinia ML builds upon this foundation.”
Allen left the firm to launch a new venture in 2020.
Infinia ML aims to make Triangle a hub for artificial intelligence, machine learning
